These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16204437

  • 1. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S, Kema IP, Haagsma EB, Boon JC, Willemse PH, den Boer JA, de Vries EG, Korf J.
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [Abstract] [Full Text] [Related]

  • 2. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A, Quarantini LC, Sampaio AS, Lyra AC, Parise CL, Paraná R, de Oliveira IR, Koenen KC, Miranda-Scippa A, Guindalini C.
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [Abstract] [Full Text] [Related]

  • 3. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 4. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
    Chapman J, Oser M, Hockemeyer J, Weitlauf J, Jones S, Cheung R.
    Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
    [Abstract] [Full Text] [Related]

  • 5. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F, Rosati S, Scuderi M, Iacomi F, Picconi R, Laghi V.
    Hepatogastroenterology; 1998 Dec; 45(23):1748-52. PubMed ID: 9840140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO, Schuchmann M, Link R, Hillenbrand H, Rahman F, Sprinzl M, Mudter J, Löhr HF, Galle PR.
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders.
    Schaefer M, Winterer J, Sarkar R, Uebelhack R, Franke L, Heinz A, Friebe A.
    Psychosomatics; 2008 Apr; 49(5):442-6. PubMed ID: 18794514
    [Abstract] [Full Text] [Related]

  • 10. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW, Loh C, Leckband SG, Endow-Eyer R, Robinson S, Meyer JM.
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Mar; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.
    J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-induced sarcoidosis.
    Doyle MK, Berggren R, Magnus JH.
    J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
    [Abstract] [Full Text] [Related]

  • 18. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications.
    Russo S, Kema IP, Bosker F, Haavik J, Korf J.
    World J Biol Psychiatry; 2009 Oct; 10(4):258-68. PubMed ID: 19921967
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.
    Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R.
    Mol Psychiatry; 2002 Oct; 7(5):468-73. PubMed ID: 12082564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.